Litigation

Recent Posts

South Carolina Judge: $327 Million Penalty Due For Marketing Of Risperdal
Posted on 6 Jun 2011 by Tom Moylan

SPARTANBURG, S.C. - (Mealey's) A South Carolina state court judge on June 3 ordered the Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary of Johnson & Johnson to pay $327,073,700 for violating the state's Unfair Trade Practices Act by using... Read More

Tags: State of South Carolina v. Janssen Pharmaceutica , Risperdal , South Carolina Unfair Trade Practices Act , State of South Carolina v. Ortho-McNeil-Janssen Pharmaceuticals , South Carolina , Marketing , package inserts , Litigation , Ortho-McNeil-Janssen Pharmaceuticals , Johnson & Johnson , antipsychotic drug

S.C. Supreme Court Oks Risperdal Unfair Trade Verdict, Lowers Penalty To $136 Million
Posted on 26 Feb 2015 by Tom Moylan

COLUMBIA, S.C. — (Mealey’s) In a 4-1 ruling, the South Carolina Supreme Court on Feb. 25 affirmed that Janssen Global Services LLC engaged in unfair trade practices through its marketing of the atypical antipsychotic drug Risperdal but shortened... Read More

Tags: drugs , Risperdal , atypical antipsychotic drug , unfair trade practices , South Carolina Unfair Trade Practices Act , product liability , State of South Carolina v. Ortho-McNeil-Janssen Pharmaceuticals , South Carolina , Litigation , Janssen Global Services LLC , Ortho-McNeil-Janssen Pharmaceuticals , torts